Novo Nordisk slammed over undisclosed payments



The United Kingdom’s Prescription Medicines Code of Practice Authority (PMCPA) publicly reprimanded Novo Nordisk, the manufacturer of diabetes drug Ozempic and weight-loss treatment Wegovy, for fa…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento